TR201716209A2 - New pharmaceutical compositions containing arformoterol and umeclidinium. - Google Patents
New pharmaceutical compositions containing arformoterol and umeclidinium. Download PDFInfo
- Publication number
- TR201716209A2 TR201716209A2 TR2017/16209A TR201716209A TR201716209A2 TR 201716209 A2 TR201716209 A2 TR 201716209A2 TR 2017/16209 A TR2017/16209 A TR 2017/16209A TR 201716209 A TR201716209 A TR 201716209A TR 201716209 A2 TR201716209 A2 TR 201716209A2
- Authority
- TR
- Turkey
- Prior art keywords
- umeclidinium
- arformoterol
- pharmaceutical compositions
- compositions containing
- new pharmaceutical
- Prior art date
Links
- BPZSYCZIITTYBL-YJYMSZOUSA-N R-Formoterol Chemical compound C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-YJYMSZOUSA-N 0.000 title abstract 2
- 229960001692 arformoterol Drugs 0.000 title abstract 2
- FVTWTVQXNAJTQP-UHFFFAOYSA-N diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Chemical compound C=1C=CC=CC=1C(C12CC[N+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 FVTWTVQXNAJTQP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004258 umeclidinium Drugs 0.000 title abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 208000006673 asthma Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mevcut buluş astım ve KOAH (Kronik Obstrüktif Akciğer Hastalığı) tedavisinde kullanılacak arformoterol ve umeklidinyum içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions containing arformoterol and umeclidinium for use in the treatment of asthma and COPD (Chronic Obstructive Pulmonary Disease).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16235A TR201716235A2 (en) | 2017-09-30 | 2017-10-20 | Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-10-20 | 2017-10-20 | New umeclidinium formulations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716209A2 true TR201716209A2 (en) | 2019-05-21 |
Family
ID=67954794
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16207A TR201716207A2 (en) | 2017-10-18 | 2017-10-20 | Pharmaceutical formulations containing vilanterol and umeclidinium. |
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16207A TR201716207A2 (en) | 2017-10-18 | 2017-10-20 | Pharmaceutical formulations containing vilanterol and umeclidinium. |
Country Status (1)
| Country | Link |
|---|---|
| TR (3) | TR201716203A1 (en) |
-
2017
- 2017-10-20 TR TR2017/16203A patent/TR201716203A1/en unknown
- 2017-10-20 TR TR2017/16207A patent/TR201716207A2/en unknown
- 2017-10-20 TR TR2017/16209A patent/TR201716209A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201716203A1 (en) | 2019-05-21 |
| TR201716207A2 (en) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021008113A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING AN IL-4R ANTAGONIST FOR USE IN THE TREATMENT OF ASTHMA. | |
| CL2016001889A1 (en) | (2s) -n - [(1s) -1-cyano-2-phenylethyl] -1,4-oxazepan-2-carboxamides as dipeptidyl peptidase 1 inhibitors. | |
| EA201691582A1 (en) | NEW PHARMACEUTICAL PREPARATIONS | |
| EA201691481A1 (en) | C5a inhibitors for the treatment of viral pneumonia | |
| IL283469A (en) | Inhalable compositions for use in the treatment of pulmonary diseases | |
| MX2021000773A (en) | COMPOSITIONS INCLUDING 15-HYDROXYIEICOSAPENTAENOIC ACID (15-HEPE) AND METHODS OF USE THEREOF. | |
| MX2017003216A (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients. | |
| MX2022013014A (en) | NEW CRYSTALLINE FORMS OF VILANTEROL TRIFENATE AND PROCEDURES FOR ITS PREPARATION. | |
| ZA201605492B (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| EA201692278A1 (en) | FORMOTHEROL AND BUDESONIDE COMBINATION FOR THE TREATMENT OF COPD | |
| EA201792282A1 (en) | METHODS OF TREATMENT OF DISEASES | |
| EA201791689A1 (en) | NEW COMPOSITIONS AND METHODS OF TREATMENT AND / OR PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | |
| JOP20200126B1 (en) | Methods of use and formulations containing dulaglutide | |
| CL2008000973A1 (en) | Compounds derived from 1-oxo-isoquinoline; preparation procedure; pharmaceutical composition; and its use in the treatment of chronic obstructive pulmonary diseases (COPD) and asthma. | |
| TR201722950A2 (en) | New pharmaceutical compositions in the treatment of COPD. | |
| TR201716199A1 (en) | New pharmaceutical compositions containing arformoterol and ipratropium. | |
| PH12016502284A1 (en) | Cough medicine containing ambroxol hydrochloride | |
| EA201990605A1 (en) | SPRAYED THIOTROPY AND FORMOTEROL COMPOSITIONS | |
| MX2021015553A (en) | Novel arginase inhibitors. | |
| EA201890789A1 (en) | CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES | |
| TR201712424A2 (en) | DRY POWDER INHALATION COMPOSITIONS | |
| TR201716201A2 (en) | Dry powder formulation containing beta-2 agonists. | |
| MX372705B (en) | PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL | |
| TR201716213A1 (en) | Pharmaceutical compositions containing indacaterol together with an anticholinergic agent. | |
| TR201716203A1 (en) | New umeclidinium formulations. |